975: Characterization and Modulation of Canine Mast Cell Derived Eicosanoids

Grant Status: Closed

Grant Amount: $34,363
Cheryl A. London, DVM PhD; Ohio State University
April 1, 2008 - March 31, 2010

Sponsor(s): Golden Retriever Foundation, Old English Sheepdog Club of America, Staffordshire Terrier Club of America

Breed(s): -All Dogs
Research Program Area: Immunology and Infectious Disease
Donate to Support this Research Program Area

Project Summary

Dr. London's research team has been investigating the production of inflammatory mediators (also known as eicosanoids) by canine mast cells that contribute to a variety of diseases such as atopy and arthritis. The purpose of their work is to determine if currently available non-steroidal antiinflammatory drugs (NSAIDs) such as Rimadyl and Zubrin (among others) are capable of modifying their production. The use of NSAIDs would be an attractive alternative to the use of corticosteroids to modulate mast cell function. The preliminary data indicate that Zubrin is very effective at blocking the production of mast cell derived eicosanoids when mast cells are exposed to standard doses of drug. Therefore, results from these studies may provide a new strategy to modify the function of mast cells in several inflammatory disorders.


Lin, T.-Y., & London, C. A. (2010). Characterization and modulation of canine mast cell derived eicosanoids. Veterinary Immunology and Immunopathology, 135(1–2), 118–127. https://doi.org/10.1016/j.vetimm.2009.11.010

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Get Canine Health News:
Please leave this field empty
American Kennel Club Canine Health Foundation, Inc

8051 Arco Corporate Dr.
Suite 300
Raleigh, NC 27617

Tax ID# 13-3813813


© 2021 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.